ATPW
KNSA icon

Ashton Thomas Private Wealth’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Ashton Thomas Private Wealth’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,361
Closed -$100K – 1268
2024
Q2 		$100K Buy
+5,361
New +$100K 0.01% 749

Other funds holding KNSA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Ashton Thomas Private Wealth's KNSA Position: Q3 2024 in Review

Ashton Thomas Private Wealth sold out of Kiniksa Pharmaceuticals (KNSA) in Q3 2024, closing a stake of 5,361 shares — an estimated $100K sold.

Ashton Thomas Private Wealth first reported a position in KNSA in Q2 2024 and held it in 1 quarter. The position peaked at $100K in Q2 2024. 176 funds tracked by Wall St. Rank hold KNSA as of Q3 2024.

  • Ashton Thomas Private Wealth reported no remaining Kiniksa Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Ashton Thomas Private Wealth sold 5,361 Kiniksa Pharmaceuticals shares in Q3 2024, an estimated $100K.
  • Ashton Thomas Private Wealth first reported a position in Kiniksa Pharmaceuticals in Q2 2024 and held it in 1 quarter.
  • Ashton Thomas Private Wealth's Kiniksa Pharmaceuticals position peaked at $100K in Q2 2024.
  • 176 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2024.

Based on Ashton Thomas Private Wealth's 13F filing for Q3 2024, filed 5 Nov 2024.